CAPOTEN Drug Patent Profile

✉ Email this page to a colleague

When do Capoten patents expire, and when can generic versions of Capoten launch?

Capoten is a drug marketed by Strides Pharma and is included in one NDA.

The generic ingredient in CAPOTEN is captopril. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the captopril profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Capoten

A generic version of CAPOTEN was approved as captopril by HIKMA INTL PHARMS on February 13^th, 1996.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CAPOTEN?
What are the global sales for CAPOTEN?
What is Average Wholesale Price for CAPOTEN?

Summary for CAPOTEN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	118
Clinical Trials:	5
DailyMed Link:	CAPOTEN at DailyMed

Drug patent expirations by year for CAPOTEN

Recent Clinical Trials for CAPOTEN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 1
Children's Cancer Hospital Egypt 57357	Phase 3
University of Nebraska	Phase 4

See all CAPOTEN clinical trials

US Patents and Regulatory Information for CAPOTEN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-005	Jan 17, 1985		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-004	Jun 13, 1995		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CAPOTEN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-005	Jan 17, 1985	⤷ Sign Up	⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CAPOTEN

See the table below for patents covering CAPOTEN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Hungary	178115	PROCESS FOR PREPARING CYCLIC DEHYDRO-IMINO-ACIDS	⤷ Sign Up
Germany	2650845		⤷ Sign Up
India	147506	PROCESS FOR THE PRODUCTION OF NEW QUINUELIDINE COMPOUNDS	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for CAPOTEN

Recent Clinical Trials for CAPOTEN

Make Better Decisions: Try a trial or see plans & pricing